Afuco™ Anti-AFP ADCC Therapeutic Antibody (Tacatuzumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human AFP. Tacatuzumab is a humanized monoclonal antibody intended for the treatment of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-713 |
| Pricing | Inquiry |
| Host | Human |
| Target | AFP |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | IF, IP, Neut, FuncS, ELISA, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |